Bioequivalence studies: single vs multiple dose.

No abstract is available for this paper.

• Publication year

  1989

• Venue

  International journal of clinical pharmacology, therapy and toxicology

• Publication date

  1989-05-01

• Fields of study

  Medicine

• Identifiers
  PMID 1601529
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Chronopharmacokinetics of theophylline after sustained release and intravenous administration to adults

  2004cited by this paper
• Statistical analysis of bioavailability studies: Parametric and nonparametric confidence intervals

  2004cited by this paper
• Disposition and clinical pharmacokinetics of theophylline after administration of a new sustained release tablet

  2004cited by this paper
• Pharmacokinetic profile of a new sustained-release theophylline pellet formulation for once-daily evening administration.

  1988cited by this paper
• A comparison of the Two One-Sided Tests Procedure and the Power Approach for assessing the equivalence of average bioavailability

  1987cited by this paper
• Theophylline steady-state pharmacokinetics: recent concepts and their application in chronotherapy of reactive airway diseases.

  1987cited by this paper
• Food interactions with once-a-day theophylline preparations: a review.

  1987cited by this paper
• Once daily theophylline: multiple-dose comparison of an encapsulated micro-osmotic system (Euphylong) with a tablet (Uniphyllin).

  1986cited by this paper
• Interactions Affecting Drug Absorption

  1984cited by this paper
• Investigation of diurnal changes in the disposition of theophylline.

  1983cited by this paper
• Sustained-release theophylline for childhood asthma: evidence for circadian variation of theophylline pharmacokinetics.

  1981cited by this paper
• Influence of food and diet on gastrointestinal drug absorption: A review

  1977cited by this paper
• Pharmacokinetic criteria for the evaluation of retard formulations

  1974cited by this paper

• Application of a method used to deconstruct a single dose pharmacokinetic profile from multiple dose data.

  2015cites this paper
• Use of Geometric Mean in Bioequivalence Trials

  2015cites this paper
• Oral Sodium Thiosulfate as Maintenance Therapy for Calcific Uremic Arteriolopathy: A Case Series

  2013cites this paper
• Statistical Considerations in the Design of Biosimilar Cancer Clinical Trials.

  2011cites this paper
• Pharmacokinetic studies in healthy volunteers in the context of in vitro/in vivo correlations

  2011cites this paper
• A practical approach for evaluating population and individual bioequivalence.

  2000cites this paper
• Why Rate of Absorption Inferences in Single Dose Bioequivalence Studies are Often Inappropriate

  1998cites this paper
• Current status of acid pump antagonists (reversible PPIs).

  1996cites this paper
• Bioavailability, Bioequivalence, and Drug Selection

  1996cites this paper
• Metrics to Characterize Concentration-Time Profiles in Single- and Multiple-Dose Bioequivalence Studies

  1995cites this paper
• International Harmonization of Regulatory Requirements for Average Bioequivalence and Current Issues in Individual Bioequivalence

  1995cites this paper
• Bioinequivalence and Drug Toxicity

  1994cites this paper
• Statistical methodology for evaluating multiple response criteria from bioequivalence and clinical equivalence trials

  1994cites this paper
• Bioequivalence requirements for generic products.

  1994cites this paper
• International Harmonization of Regulatory Bioequivalence Requirements

  1993cites this paper
• An Evaluation of the Effect of Food on the Oral Bioavailability of Sustained‐Release Morphine Sulfate Tablets (ORAMORPH SR) After Multiple Doses

  1992cites this paper
• Controversies in Bioequivalence Studies

  1992cites this paper